Piper Sandler Starts Crescent Biopharma Inc (CBIO) at Overweight
Tweet
Share
E-mailGet Alerts CBIO Hot Sheet
Price: $17.14 +3.07%
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Biren Amin initiates coverage on Crescent Biopharma Inc (NASDAQ: CBIO) with a Overweight rating.
For an analyst ratings summary and ratings history on Crescent Biopharma Inc click here. For more ratings news on Crescent Biopharma Inc click here.
Shares of Crescent Biopharma Inc closed at $11.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Berkshire adds significantly to Alphabet position, starts small position in DR Horton
- Mosaic sets pricing for tender offers on up to $1.4B in debt
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
